Evidence map›Paper›PMID 18549418›Full record

Trial reportActa paediatrica (Oslo, Norway : 1992)2008

Nasal high-frequency ventilation for premature infants.

Tarah T Colaizy, Usama M M Younis, Edward F Bell, Jonathan M Klein

2 registry-linked trialsAbstract readClinical Trial
In one paragraph

Trial report in Acta paediatrica (Oslo, Norway : 1992), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02543125 naunknown statusnot on this mapstarted 2016, after this paper: background citation

Nasal High Frequency Oscillatory Versus Nasal Intermittent Positive Pressure Ventilation in Neonate After Extubation

TypeinterventionalSponsorGao WeiWeiRan2016 to 2016Enrolled75ConditionsRespiratory InsufficiencyArmsNIPPV, NHFOV
NCT02772835 nacompletednot on this mapstarted 2016, after this paper: background citation

Nasal HFOV vs Nasal CPAP: Effects on Gas Exchange for the Treatment of Neonates Recovering From Respiratory Distress Syndrome. A Multicenter Randomized Controlled Trial

TypeinterventionalSponsorFondazione Poliambulanza Istituto OspedalieroRan2016 to 2017Enrolled30ConditionsRespiratory Distress Syndrome, Preterm BirthArmsMedin-cno
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. [Research advances in noninvasive high-frequency oscillatory ventilation in neonates].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2017
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tarah T ColaizyDepartment of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA. tarah-colaizy@uiowa.edu
Usama M M Younis
Edward F Bell
Jonathan M Klein
University of Iowa · US

Funding

XANTHINE OXIDASE PRODUCTS IN MODULATION OF ENDOTHELIAL DYSFUNCTIONM01RR000059 · NCRR · UNIVERSITY OF IOWA · PI FAKHRY, ALI · 1985 to 2007
$22.3M
NCRR NIH HHS M01 RR000059NCRR NIH HHS M01 RR00059
6 · The paper itself

Abstract

aimTo assess the use of nasal high-frequency ventilation (HFV) to provide noninvasive ventilatory support for very low birthweight (VLBW) infants. STUDY

designVLBW infants, >7 days of age on nasal continuous positive airway pressure (CPAP), were placed on nasal HFV for 2 h using the Infant Star high-frequency ventilator (Mallinckrodt, Inc., St. Louis, MO, USA). Mean airway pressure was set to equal the previous level of CPAP, and amplitude was adjusted to obtain chest wall vibration. Capillary blood was sampled before starting HFV and after 2 h to determine change in pH and partial pressure of carbon dioxide (pCO(2)).

resultsFourteen subjects were studied, 10 males and 4 females. Gestational age was 26-30 weeks (median 27). Age at study was 18-147 days (median 30). Median birth weight was 955 g; median weight at study was 1605 g. Nasal CPAP pressure was 4-7 cm H(2)O (mean 5). Amplitude was 30-60 (median 50). After 2 h, PCO(2) (mean 45 torr) was significantly lower than initial PCO(2) (mean 50 torr) (p = 0.01), and pH had increased significantly (7.40 vs. 7.37, p = 0.04).

conclusionsNasal HFV is effective in decreasing pCO(2) in stable premature infants requiring nasal CPAP support. Long-term use of nasal HFV requires further study.

Indexed as

High-Frequency VentilationInfant, PrematureCarbon DioxideContinuous Positive Airway PressureFemaleHumansInfantInfant, NewbornInfant, Very Low Birth WeightMaleProspective StudiesRespiratory Distress Syndrome, NewbornCarbon Dioxide

Identifiers

PMID18549418
PMCPMC3976963
OpenAlexW2014991186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.